|
Field
Trial Status
|
Before
completed
|
After
on_going
|
|
Field
Trial Start Date
|
Before
December 01, 2017
|
After
November 09, 2018
|
|
Field
Trial End Date
|
Before
June 01, 2019
|
After
August 10, 2019
|
|
Field
Last Published
|
Before
July 30, 2019 05:27 PM
|
After
August 04, 2019 07:32 AM
|
|
Field
Intervention (Public)
|
Before
The study was a Single-Blind, Randomized Controlled Trial comparing psychological intervention group, based on Transdiagnostic therapy principles, with a control group. The statistical population consisted of all females with MS living in Capital and around. First, a group of 400 females with MS who officially registered in MS clinics from October 2010 to October 2016, was selected. They invited over telephone, emails, and were notified about a summary of the objectives of the study.
|
After
The study was a Single-Blind
Randomized trail control
2 group
Evaluater blind
Randomization
|
|
Field
Intervention Start Date
|
Before
November 02, 2018
|
After
May 02, 2019
|
|
Field
Intervention End Date
|
Before
February 01, 2019
|
After
August 06, 2019
|
|
Field
Primary Outcomes (Explanation)
|
Before
|
After
Scid
Hads
Pswq
|
|
Field
Experimental Design (Public)
|
Before
The inclusion criteria included:
1. Diagnosis of MS for three years or more
2. Fluent in Persian, at least 18 years of age
4. Received at least one current diagnostic of a valid depression disorder and an anxiety disorder on Structural Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fourth. Edition Axis I Disorders.
5. Received at least one self-report score without the cut-off range specified for screening measureS
5. Willing to participate in the research.
6. Fill and signature consent
7. Medical agreement for participation
Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or lactation,
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history or drug dependence except for nicotine
7. Absenteeism for more than three sessions
8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia
|
After
The inclusion criteria included:
1. Diagnosis of MS for three years or more
2. Fluent in Persian, at least 18 years of age
4. Meet scid
5. Received at least one self-report rch.
6. Fill and signature consent
7. Medical agreement for participation
Exclusion criteria included
1. The initial diagnosis of other psychiatric diagnoses, compensatory behaviors or cleansing,
2. Other Chronic physical illnesses (such as insulin-dependent diabetes and chemotherapy for cancer)
3. Pregnancy or lactation,
4. Evidence of current or past schizophrenia, psychosis, or organic mental disorder, bipolar disorder, or organic mental disorder
6. Drug abuse history or drug dependence except for nicotine
7. Absenteeism for more than three sessions
8. Receiving psychological interventions during one last year.
9. Presence of comorbid neurological disorders such as Alzheimer, Parkinson's disease, Dementia
|
|
Field
Planned Number of Observations
|
Before
250 women
|
After
130 women
|
|
Field
Keyword(s)
|
Before
Education, Health, Other
|
After
Education, Electoral, Health, Other
|
|
Field
Did you obtain IRB approval for this study?
|
Before
No
|
After
Yes
|
|
Field
Secondary Outcomes (End Points)
|
Before
|
After
Scid
Hads
Pswq
Ders
Erq
|
|
Field
Secondary Outcomes (Explanation)
|
Before
|
After
All measures
|
|
Field
Pi as first author
|
Before
No
|
After
Yes
|